Blood Test Estimates Alzheimer's Risk Ten Years Before Symptoms

A new blood test developed by Spanish researchers can estimate the risk of developing Alzheimer's symptoms up to a decade before they appear, offering a minimally invasive way to identify individuals at high risk. The test measures the biomarker %p-tau217 and has a negative predictive value of over 90%, meaning a negative result reliably rules out clinical decline for ten years Source: elconfidencial.

How the test works

The %p-tau217 biomarker, measured in blood, reflects Alzheimer's-related biological processes. Unlike binary tests, it stratifies patients into four risk levels: low, intermediate, elevated, and high Source: elmundoes. 'We understand it as a risk gradient, not simply a positive or negative,' said lead researcher Jesús Silva Rodríguez Source: elconfidencial.

Key findings

• In a 12-year study of nearly 1,000 cognitively healthy adults (recruited in Madrid), 16.2% developed mild cognitive impairment or dementia, and 6.7% progressed to dementia Source: elmundoes.
• A positive result in the highest-risk group was associated with a 55% probability of progression at 5 years and 72% at 10 years, but even then, a significant portion did not develop symptoms Source: elmundoes.
• The test's main strength is ruling out risk: a negative result provides over 90% certainty of no clinical symptoms in the next decade Source: infobae.

Implications

Researchers emphasize the test is not a deterministic prediction but a tool for selecting high-risk individuals for closer monitoring or clinical trials. 'The possibility of identifying people at higher risk with a simple blood test will facilitate prevention strategies,' said Pascual Sánchez-Juan, senior author Source: infobae. It could also reduce unnecessary invasive procedures like lumbar punctures for low-risk individuals Source: elmundoes.